X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2249) 2249
Newsletter (19) 19
Book Chapter (14) 14
Magazine Article (7) 7
Dissertation (4) 4
Conference Proceeding (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1878) 1878
science & technology (1631) 1631
life sciences & biomedicine (1607) 1607
male (1299) 1299
female (1265) 1265
clarithromycin (993) 993
middle aged (980) 980
clarithromycin - therapeutic use (963) 963
adult (939) 939
anti-bacterial agents - therapeutic use (837) 837
helicobacter infections - drug therapy (807) 807
clarithromycin - adverse effects (749) 749
aged (717) 717
helicobacter pylori (713) 713
drug therapy, combination (700) 700
clarithromycin - administration & dosage (626) 626
anti-bacterial agents - adverse effects (620) 620
treatment outcome (605) 605
gastroenterology & hepatology (551) 551
pharmacology & pharmacy (496) 496
anti-bacterial agents - administration & dosage (473) 473
helicobacter pylori - drug effects (431) 431
amoxicillin - therapeutic use (369) 369
adolescent (328) 328
amoxicillin - administration & dosage (299) 299
prospective studies (285) 285
microbiology (281) 281
amoxicillin (273) 273
antibiotics (270) 270
aged, 80 and over (245) 245
drug administration schedule (237) 237
anti-ulcer agents - therapeutic use (225) 225
drug interactions (219) 219
clarithromycin - pharmacology (218) 218
helicobacter infections - microbiology (218) 218
general & internal medicine (210) 210
abridged index medicus (202) 202
helicobacter infections (196) 196
amoxicillin - adverse effects (194) 194
infectious diseases (193) 193
omeprazole - therapeutic use (192) 192
health aspects (182) 182
medicine, general & internal (181) 181
care and treatment (180) 180
anti-bacterial agents - pharmacology (175) 175
metronidazole - therapeutic use (172) 172
omeprazole - administration & dosage (170) 170
double-blind method (169) 169
drug therapy (169) 169
anti-ulcer agents - administration & dosage (168) 168
metronidazole - administration & dosage (161) 161
2-pyridinylmethylsulfinylbenzimidazoles (157) 157
child (151) 151
omeprazole - analogs & derivatives (148) 148
infections (146) 146
young adult (146) 146
drug resistance, bacterial (144) 144
lansoprazole (143) 143
metronidazole (143) 143
time factors (139) 139
microbial sensitivity tests (138) 138
helicobacter pylori - isolation & purification (134) 134
risk factors (132) 132
research (131) 131
levofloxacin (130) 130
proton pump inhibitors (130) 130
proton pump inhibitors - therapeutic use (130) 130
anti-ulcer agents - adverse effects (127) 127
omeprazole - adverse effects (127) 127
follow-up studies (126) 126
breath tests (124) 124
patients (124) 124
medicine & public health (120) 120
retrospective studies (119) 119
azithromycin (117) 117
eradication (117) 117
helicobacter infections - diagnosis (117) 117
peptic ulcer - drug therapy (113) 113
child, preschool (112) 112
macrolides (108) 108
analysis (107) 107
clinical trials (107) 107
therapy (105) 105
animals (103) 103
helicobacter infections - complications (103) 103
internal medicine (103) 103
proton pump inhibitors - administration & dosage (100) 100
administration, oral (98) 98
dose-response relationship, drug (98) 98
duodenal ulcer - drug therapy (98) 98
metronidazole - adverse effects (98) 98
dosage and administration (97) 97
drug resistance (97) 97
erythromycin (95) 95
omeprazole (95) 95
immunology (91) 91
gastritis - drug therapy (89) 89
mycobacterium avium-intracellulare infection - drug therapy (89) 89
drug therapy, combination - therapeutic use (86) 86
clarithromycin - pharmacokinetics (84) 84
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2171) 2171
Japanese (59) 59
French (29) 29
Spanish (29) 29
German (27) 27
Russian (13) 13
Portuguese (11) 11
Chinese (9) 9
Dutch (5) 5
Korean (5) 5
Polish (5) 5
Danish (3) 3
Italian (3) 3
Hebrew (1) 1
Hungarian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gut, ISSN 0017-5749, 09/2016, Volume 65, Issue 9, pp. 1439 - 1446
ObjectiveThe objective of this study was to assess the efficacy, safety and tolerability of vonoprazan, a novel potassium-competitive acid blocker, as a... 
antibiotic therapy | clinical trials | Helicobacter pylori infection | helicobacter pylori - treatment | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Humans | Middle Aged | Helicobacter Infections - complications | Helicobacter pylori - drug effects | Male | Drug Monitoring - methods | Proton Pump Inhibitors - administration & dosage | Pyrroles - administration & dosage | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Metronidazole - adverse effects | Peptic Ulcer - diagnosis | Pyrroles - adverse effects | Adult | Female | Amoxicillin - administration & dosage | Anti-Bacterial Agents - adverse effects | Helicobacter Infections - diagnosis | Lansoprazole - administration & dosage | Proton Pump Inhibitors - adverse effects | Double-Blind Method | Drug Administration Schedule | Clarithromycin - adverse effects | Metronidazole - administration & dosage | Treatment Outcome | Drug Therapy, Combination - methods | Lansoprazole - adverse effects | Sulfonamides - adverse effects | Amoxicillin - adverse effects | Helicobacter pylori - isolation & purification | Anti-Bacterial Agents - administration & dosage | Peptic Ulcer - drug therapy | Breath Tests - methods | Peptic Ulcer - etiology | Sulfonamides - administration & dosage | Usage | Safety and security measures | Research | Helicobacter pylori | Antacids | Index Medicus | Abridged Index Medicus | Helicobacter Pylori | HELICOBACTER PYLORI - TREATMENT | CLINICAL TRIALS | 1506 | ANTIBIOTIC THERAPY | HELICOBACTER PYLORI INFECTION
Journal Article
JAMA internal medicine, ISSN 2168-6106, 10/2014, Volume 174, Issue 10, pp. 1605 - 1612
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 11/2009, Volume 180, Issue 9, pp. 896 - 902
Rationale: The optimal therapeutic regimen and duration of treatment for Mycobacterium abscessus lung disease is not well established. Objectives: To assess... 
Treatment outcome | Lung diseases | Mycobacterium abscessus | Atypical mycobacteria | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Sputum - microbiology | Lung - microbiology | Cefoxitin - therapeutic use | Lung Diseases - microbiology | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Lung - diagnostic imaging | Lung Diseases - drug therapy | Anti-Bacterial Agents - therapeutic use | Sputum - drug effects | Liver - drug effects | Mycobacterium Infections, Nontuberculous - microbiology | Adult | Female | Anti-Bacterial Agents - adverse effects | Retrospective Studies | Drug Therapy, Combination | Neutropenia - chemically induced | Chemical and Drug Induced Liver Injury - etiology | Doxycycline - adverse effects | Ciprofloxacin - adverse effects | Nontuberculous Mycobacteria - drug effects | Clarithromycin - adverse effects | Doxycycline - therapeutic use | Ciprofloxacin - therapeutic use | Anti-Infective Agents - therapeutic use | Treatment Outcome | Clarithromycin - therapeutic use | Thrombocytopenia - chemically induced | Nontuberculous Mycobacteria - isolation & purification | Amikacin - adverse effects | Amikacin - therapeutic use | Lung - drug effects | Cefoxitin - adverse effects | Mycobacterium Infections, Nontuberculous - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 377, Issue 9769, pp. 905 - 913
Journal Article
Journal Article
Gut, ISSN 0017-5749, 11/2016, Volume 65, Issue 11, pp. 1784 - 1792
Journal Article
The American journal of gastroenterology, ISSN 1572-0241, 02/2006, Volume 101, Issue 2, pp. 243 - 247
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 10/2018, Volume 2018, Issue 10, pp. CD009764 - CD009764
Background There has been renewal of interest in the use of prophylactic antibiotics to reduce the frequency of exacerbations and improve quality of life in... 
Fluoroquinolones | Quinolines | Clarithromycin | Lungs & airways | Drug Administration Schedule | Pulmonary Disease, Chronic Obstructive | Azithromycin | Antibiotic Prophylaxis | Roxithromycin | Erythromycin | Moxifloxacin | Disease Progression | Randomized Controlled Trials as Topic | Trimethoprim, Sulfamethoxazole Drug Combination | Chronic obstructive pulmonary disease (stable) | Amoxicillin | Anti‐Bacterial Agents | Aza Compounds | Clavulanic Acid | Quality of Life | Chronic obstructive pulmonary disease, stable ‐ pharmacotherapy | Medicine General & Introductory Medical Sciences | Other medications | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Aza Compounds - therapeutic use | Humans | Anti-Bacterial Agents - therapeutic use | Anti-Bacterial Agents - adverse effects | Roxithromycin - adverse effects | Roxithromycin - therapeutic use | Antibiotic Prophylaxis - methods | Clarithromycin - therapeutic use | Trimethoprim, Sulfamethoxazole Drug Combination - adverse effects | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Erythromycin - therapeutic use | Clavulanic Acid - adverse effects | Clavulanic Acid - therapeutic use | Azithromycin - adverse effects | Moxifloxacin - therapeutic use | Azithromycin - therapeutic use | Amoxicillin - therapeutic use | Amoxicillin - adverse effects | Aged | Quinolines - therapeutic use | Pulmonary Disease, Chronic Obstructive - drug therapy | Index Medicus
Journal Article